Clinical Trial Update: ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 trial of ALPN-101 (Acazicolcept) for systemic lupus erythematosus has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• ALPN-101 (Acazicolcept)

Snippet

Sponsor: Alpine Immune Sciences Inc, A Subsidiary of Vertex | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2025-08-15